ChristopherEingWeeMD(He/Him)

PubMed

• Safety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With Metastatic Urothelial Carcinoma Requiring Treatment Interruption or Discontinuation D...
  Amanda Nizam, Ryan K Rader, Alice Tzeng, Wei Wei, Iris Yeong-Fung Sheng, Allison Martin, Christopher E Wee, Timothy D Gilligan, Shilpa Gupta, Moshe C Ornstein> ;Clinical Genitourinary Cancer. 2024 Apr 1
• 1 citations
  Platinum ineligibility and survival outcomes in patients with advanced urothelial carcinoma receiving first-line treatment.
  Shilpa Gupta, Alexander Andreev-Drakhlin, Otto Fajardo, Marcella Fassò, Jorge A Garcia, Christopher Wee, Carsten Schröder> ;Journal of the National Cancer Institute. 2024 Apr 5
• Management of testicular germ cell tumors.
  Christopher E Wee, Timothy D Gilligan> ;Clinical Advances in Hematology & Oncology. 2023 Apr 1
• 2 citations
  Lineage plasticity and treatment resistance in prostate cancer: the intersection of genetics, epigenetics, and evolution.
  Jarrell Imamura, Shinjini Ganguly, Andrew Muskara, Ross S Liao, Jane K Nguyen, Christopher Weight, Christopher E Wee, Shilpa Gupta, Omar Y Mian> ;Frontiers in Endocrinology. 2023 Jan 1
• 3 citations
  Chemotherapy with atezolizumab for small cell or neuroendocrine carcinoma of the prostate: A single institution experience.
  Christopher E. Wee, Brian A. Costello, Jacob J. Orme, J. Fernando Quevedo, Lance C. Pagliaro> ;The Prostate. 2021 Jul 12
• The Potential and Limitations of Precision Oncology: Lessons Learned from Whole-Exome Sequencing in an Exceptional Response to Everolimus in Advanced Renal Cell Carcin...
  Amanda Pilling, Christopher Wee, Eliezer Bar-Meir, Gregory Dyson, Ok Hwang, Nilesh S. Gupta, Dhananjay Chitale, Clara Hwang> ;Case Reports in Oncology. 2021 May 1
• 2 citations
  Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy (PRRT).
  Christopher E. Wee, Ayca Dundar, Rachel A. Eiring, Mohamed Badawy, Timothy J. Hobday, A Tuba Kendi, Annie T. Packard, Thorvardur R. Halfdanarson> ;Journal of Nuclear Medicine. 2021 Mar 1
• 47 citations
  Evaluating Unconscious Bias: Speaker Introductions at an International Oncology Conference.
  Narjust Duma, Urshila Durani, Cynthia Brooke Woods, Lionel A. Kankeu Fonkoua, Joselle Cook, Christopher E. Wee, Harry E Fuentes, Miguel Gonzalez-Velez, Martina Murphy,...> ;Journal of Clinical Oncology. 2019 Oct 11
• Surveillance after pediatric thymoma resection
  Christopher E. Wee, Julian R. Molina> ;Mediastinum. 2019 May 30
• Analysis of Origins of Admission for Solid Tumor Oncology Inpatients: Disease Severity and Outcomes.
  Christopher E. Wee, Lindsey Martin Goodman, Leticia Varella, Lisa Rybicki, Alberto J. Montero, Bassam Estfan, Carolyn Best, James P. Stevenson> ;Journal of Oncology Practice. 2017 Jun 21
• Join now to see all

Abstracts/Posters

• WhatÍs in a Name? a Gender-Based Analysis of Speaker Introductions at the American Society of Hematology Annual Meeting
  Christopher E. Wee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Risk Factors for Increased Length of Stay (LOS) in Patients with Hematological Malignancies Electively Admitted for Chemotherapy 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019